Status:
COMPLETED
An Innovative Probiotic Product With Antiallergic Properties
Lead Sponsor:
Children's Memorial Health Institute, Poland
Conditions:
Atopic Dermatitis
Food Allergy
Eligibility:
All Genders
1-24 years
Phase:
NA
Brief Summary
Allergic diseases are currently one of the most important problem in medicine. Research confirms that probiotics administered during the formation of the intestinal ecosystem and the maturation of the...
Eligibility Criteria
Inclusion
- diagnosis of atopic dermatitis according to Hanifin and Rajka criteria,
- age under 2 years (24 months)
- the SCORAD index \>10
- suspected allergy to cow's milk protein
Exclusion
- acute infections of skin,
- presence of other severe diseases
- treatment with systemic corticosteroids
- treatment with antibiotics for at least 6 weeks prior to study enrollment
- use of probiotics for the last 6 weeks prior to study enrollment
Key Trial Info
Start Date :
June 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2015
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04738565
Start Date
June 1 2012
End Date
December 31 2015
Last Update
February 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Children's Memorial Health Institute
Warsaw, Poland, 04-730